Company: BIAF
Filing Date: 2025-09-18
Form Type: 424B3
Source: 0001493152-25-014066
Chunk: 1

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-18
Form: 424B3
Chunk 1
---
 offering (the “May Offering”) pursuant to the terms of a securities purchase agreement dated May 5, 2025 (the “May Purchase Agreement”)and (v) 162,130 shares of Common Stock issuable
upon the exercise of warrants to purchase 162,130 shares of Common Stock issued to designees of WallachBeth Capital LLC (“WallachBeth”),
of which (a) 33,000 shares of Common Stock issuable upon the exercise of warrants (the “Inducement Advisor Warrants”) to
purchase 33,000 shares of Common Stock (the “Inducement Advisor Warrant Shares”) were partial compensation for WallachBeth
acting as financial advisor in connection with the Warrant Inducement Private Placement pursuant to the terms of a financial advisory
agreement dated as of August 13, 2025, (the “Advisory Agreement”) and (b) 129,130 shares of Common Stock issuable upon the
exercise of warrants (the “Placement Agent Warrants”) to purchase 129,130 shares of Common Stock (the “Placement Agent
Warrant Shares”) were partial compensation for WallachBeth acting as placement agent in connection with the August 2025 Private
Placement pursuant to the terms of a placement agency agreement dated as of August 13, 2025, (the “Placement Agency Agreement”).
Each of the August 2025 Private Placement and the Warrant Inducement Private Placement closed on August 14, 2025. The Investors, the
Warrant Inducement Holders, the May 2025 Warrant Holders and the designees of WallachBeth that received Inducement Advisor Warrants
and/or Placement Agent Warrants are collectively referred to herein as the “Selling Stockholders.” The Private Warrants,
the Inducement Warrants, the Inducement Advisor Warrants, the May 2025 Warrants and the Placement Agent Warrants are collectively
referred to herein as the “Common Warrants.” The Conversion Shares, Private Warrant Shares, the Inducement Warrant Shares,
the Inducement Advisor Warrant Shares the May 2025 Warrant Shares and the Placement Agent Warrant Shares are collectively referred
to herein as the “Resale Shares.”

We are filing this registration statement on Form S-1, of which this prospectus forms a part, to fulfill our contractual obligations to provide for the registration of the resale of the Common Warrant Shares by Selling Stockholders. See